The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross-Sectional Study.

Tuono RM, Simo JL, Tchouanmo PRN, Yong IWS, Njopwouo MS, Tayou CT

Open source

DOI
10.1155/ah/1400762
Published
2026
Container
Advances in hematology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/ah/1400762,
  title = {The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross-Sectional Study.},
  author = {Tuono RM and Simo JL and Tchouanmo PRN and Yong IWS and Njopwouo MS and Tayou CT},
  year = {2026},
  journal = {Advances in hematology},
  doi = {10.1155/ah/1400762},
  url = {https://doi.org/10.1155/ah/1400762}
}

RIS

TY  - JOUR
TI  - The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross-Sectional Study.
AU  - Tuono RM
AU  - Simo JL
AU  - Tchouanmo PRN
AU  - Yong IWS
AU  - Njopwouo MS
AU  - Tayou CT
PY  - 2026
JO  - Advances in hematology
DO  - 10.1155/ah/1400762
UR  - https://doi.org/10.1155/ah/1400762
ER  - 

APA

RM, T., JL, S., PRN, T., IWS, Y., MS, N., & CT, T. (2026). The Natural Coagulation Inhibitors, Inflammation, and Thrombotic Risk in Sickle Cell Patients in Cameroon: An Analytical Cross-Sectional Study.. Advances in hematology. https://doi.org/10.1155/ah/1400762

Source records